Center for drug safety evaluation and research (CDSER) undertakes IND-enabling non-clinical safety assessment research for chemical drugs, biotechnological products and traditional medicines in compliance with international GLP regulations (FDA/OCED/NMPA). Several hundred new drugs have been finished and submitted to FDA/OECD/NMPA. CDSER has been awarded second rate of the National Scientific Award and first rate in the Science and Technology Award by Chinese Pharmaceutical Association and so on. Over hundred papers have been published.